Chest
EditorialsThe Seduction of Asthma Severity Categorization
References (9)
- et al.
Relationship between airway obstruction and respiratory symptoms in adult asthmatics
Chest
(1998) - et al.
Asthma control versus asthma severity
J Allergy Clin Immunol
(1996) Expert panel report II: Guidelines for the diagnosis and management of asthma
(1997)- et al.
Asthma guidelines: an assessment of physician understanding and practice
Am J Respir Crit Care Med
(1999)
Cited by (7)
Chronic Medical Conditions
2018, Braddom's Rehabilitation Care: A Clinical HandbookPatients' perception of asthma severity
2007, Respiratory MedicineIntensity of bronchial hyperresponsiveness and asthma relapse risk in the young adult
2007, Allergologia et ImmunopathologiaPrognostic factors of asthma severity: A 9-year international prospective cohort study
2006, Journal of Allergy and Clinical ImmunologyAssessment of asthma control and severity
2004, Annals of Allergy, Asthma and ImmunologyBronchial reactivity indices are determinants of health-related quality of life in patients with stable asthma
2010, ThoraxCitation Excerpt :Unlike these authors, our data demonstrate that the negative impact of AHR on HRQL is not limited to the patients with the most severe asthma given that, in those patients with intermittent or persistent mild asthma, the AQLQ total score maintained a significant relationship with DRS (r=−0.796, p<0.001), CIR (r=−0.697, p<0.001) and BRI (r=−0.819, p<0.001). As our study took into account the therapeutic stage of the patients, the different criteria used to evaluate severity or the known variability in the perception of the severity by either the physician or the patient him/herself30–32 could justify this discrepancy at least in part. The relationship between AHR and HRQL could be attributed to a structural disorder of the airways, in such a way that those patients with small airways of a smaller calibre would be more likely to develop a reduction in mid-expiratory flow, which would intensify breathing difficulty or oppression.8
- 1
Dr. Colice has acted as a consultant for GlaxoSmithKline, Aventis, Novartis, Sepracor, Altana, Kos, Om, Schering Plough, Pfizer, Boehringer Ingelheim, and 3M pharmaceutical companies, Washington, DC